医学
随机对照试验
荟萃分析
冲程(发动机)
汤剂
不利影响
内科学
缺血性中风
临床试验
传统医学
物理疗法
缺血
机械工程
工程类
作者
Zhou Xiu,Tianyu Shao,Xiuzhen Xie,Minrui Ding,Xumin Jiang,Pingping Su,Zhuqing Jin
标识
DOI:10.1016/j.jep.2021.114693
摘要
The aim of this study was to evaluate the efficacy and safety of Tongqiao Huoxue Decoction (TQHXT) in the treatment of acute ischemic stroke (AIS); Study Design: A total of 17 randomized controlled trials, involving 1489 AIS patients, were included for data analyses.All randomized controlled trials (RCTs) of TQHXT in the treatment of acute ischemic stroke before September 2020 were retrieved from seven electronic databases, including PubMed, Web of Science, Central, CNKI, CBM, Wanfang, and VIP. Data were analyzed by RevMan 5.3 software, and quality was evaluated by GRADEpro; Results: Results showed that, while TQHXT demonstrated undeniable positive effects in clinical effective rate, neurological deficit scores, activities of daily living (ADL) scores, and hemorheology (including HCT; fibrinogen; plasma viscosity and platelet adherence rate), adverse events (AE) require further study; and Conclusions: This study provides evidence that TQHXT is an effective treatment for acute ischemic stroke. However, due to the limited quality of the included studies, the above conclusion needs to be further verified by stricter randomized controlled, double-blind, large-sample, high-quality trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI